Diamyd Medical: Phase II results will be released June 16, 2003 STOCKHOLM, Sweden, May 27, 2003 (PRIMEZONE) -- Diamyd Medical (O-list) (Stockholm:DIAMb) is planning to present its phase II study with the diabetes vaccine Diamyd in a press release on Monday June...

Diamyd Medical AB Second Quarter Report 02/03 STOCKHOLM, Sweden, April 16, 2003 (PRIMEZONE) -- Diamyd Medical AB (publ) (SSE:DIAMb): December 1, 2002 - February 28, 2003 - Sales during the period were SEK 358,000 (393,000). - Earnings ...

All patients in Diamyd's diabetes study included STOCKHOLM, Sweden, Jan. 10, 2003 (PRIMEZONE) -- Diamyd Medical (SSE:DIAMb) is developing a GAD vaccine for insulin-dependent diabetes. The company reports that patient recruitment has been concluded,...

Diamyd Medical's Competitor Signs Multimillion Dollar Agreement STOCKHOLM, Sweden, Aug. 7, 2002 (PRIMEZONE) -- Aventis has entered into an agreement with Peptor from Israel that involves Aventis investing more than USD 100 million in Peptor's diabetes project....